With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

(Reuters) -French train maker Alstom reported an annual free cash flow well above market expectations on Wednesday, in a sign ...

The Canadian Medical Association (CMA) congratulates Canada's Minister of Health Marjorie Michel and the entire new federal cabinet on their appointments today. The CMA is eager to collaborate with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For comparison, Roche's oral GLP-1 achieved 6.1% placebo-adjusted weight at the optimum dose in its phase 1 trial, while Viking's VK2735 – like Zepbound, a dual GLP-1 and GIP agonist – also ...

Aditya Birla Capital Ltd. Board Meeting : Audited Results & Fund Raising GlaxoSmithKline Pharmaceuticals Ltd. Board Meeting : Audited Results & Final Dividend Max Financial Services Ltd. Board Meeting ...